デフォルト表紙
市場調査レポート
商品コード
1555536

医薬品懸濁液市場：タイプ別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Pharmaceutical Suspension Market, By Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 392 Pages
納期
2～3営業日
カスタマイズ可能
医薬品懸濁液市場：タイプ別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月20日
発行: AnalystView Market Insights
ページ情報: 英文 392 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

レポートハイライト

医薬品懸濁液の市場規模は2023年に563億4,532万米ドルとなり、2024年から2032年にかけてCAGR 4.3％で拡大

医薬品懸濁液市場-市場力学

ドラッグデリバリー技術の進歩と研究開発投資の増加が市場需要を促進する見込み

ドラッグデリバリーシステムと製剤技術の革新は、懸濁液の有効性と安定性を高める。安定した高品質の懸濁製剤を製造する技術の向上は、複雑な薬剤のニーズを満たすのに役立ち、市場の成長を後押ししています。糖尿病、がん、呼吸器疾患などの慢性疾患の増加により、懸濁剤を含む様々な医薬品製剤の需要が高まっています。これらの製剤は、液状の薬剤を必要とする患者にとって特に有用です。さらに、より優れた混合・粉砕技術などの製造工程の進歩は、医薬品懸濁液の品質と一貫性を向上させ、製造業者と消費者の双方にとってより魅力的なものとなっています。

製薬会社による、新しく改良された製剤を生み出すための研究開発投資の増加は、市場の成長を促進します。これには、新薬用懸濁液の開発や既存製品の改良が含まれます。さらに、制酸剤、咳止めシロップ、鎮痛剤など、懸濁液の形をした一般用医薬品（OTC）の需要は、便利で利用しやすい治療を好む消費者の好みに後押しされて、伸び続けています。

医薬品懸濁液市場-主な洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約4.3%のCAGRで年間成長すると予測されています。

タイプ別セグメンテーションに基づくと、非経口セグメントは、ドラッグデリバリーのための迅速かつ直接的なルートにより、2023年に最大の市場シェアを示すと予測されました。

適応症別では、抗がん剤の入手可能性が高いことから、2023年にはがん領域が主要適応症となった。

エンドユーザー別では、がんや慢性疾患の有病率の増加により、2023年には病院が主要なエンドユーザーとなった。

地域別では、懸濁液ベースの医薬品が広く利用可能であることから、北米が2023年に収益でリードしました。

医薬品懸濁液市場-セグメンテーション分析：

医薬品懸濁液の世界市場は、タイプ、適応症、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプにより、経口、非経口、その他の3つに分類されます。非経口剤が市場を独占しています。非経口剤製剤の進歩とその採用拡大が主に市場成長を後押ししています。

市場は適応症別に、がん、消化器、神経、感染症、その他の5つに分類されます。がん分野は市場を独占しています。治療領域と技術の開発が進んでいることが、同分野の成長を刺激しています。

エンドユーザー別では、病院、診療所、その他に分類されます。病院分野が市場を独占しており、予測期間中も高い優位性を維持すると予想されます。慢性疾患治療と治療の改善が、同分野の成長を促進しています。

医薬品懸濁液市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。アジア太平洋は、人口の多さ、ヘルスケア支出の増加、慢性疾患の有病率の増加により、主要市場となっています。この地域には、中国、インド、日本など、医薬品製造の重要な拠点となっている国があります。中東・アフリカ市場は他地域に比べ相対的に発展途上だが、ヘルスケアへのアクセスが向上し、様々な治療オプションに対する認識が高まっているため、関心が高まっています。

医薬品懸濁液市場-競合情勢：

医薬品懸濁液市場は、継続的な進歩と競争戦略がその進化を形成しており、著しくダイナミックです。技術革新や戦略的パートナーシップを活用する企業主要企業は自社製品を差別化し、競争力を維持するために技術革新に注力しています。これには、新しい製剤の開発、ドラッグデリバリーシステムの改良、研究開発への投資などが含まれます。企業はしばしば学術機関や研究機関と協力し、ドラッグデリバリーの科学を発展させ、革新的な懸濁製剤を開発しています。

2023年8月、世界のバイオ医薬品の主要企業であるメルク社は、ザイールエボラウイルスという病気に対するERVEBOの適応拡大承認を発表しました。

2023年11月、テバ・ファーマシューティカル・インダストリーズとロイヤリティ・ファーマ・ピーエルシーが提携し、臨床研究プログラムを加速。

目次

第1章 医薬品懸濁液市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医薬品懸濁液の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 医薬品懸濁液産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 医薬品懸濁液市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 医薬品懸濁液市場情勢

  • 医薬品懸濁液市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医薬品懸濁液市場- タイプ別

  • 概要
    • セグメントシェア分析
    • 経口
    • 非経口
    • その他

第8章 医薬品懸濁液市場- 適応症別

  • 概要
    • セグメントシェア分析
    • がん
    • 胃腸
    • 神経学的
    • 感染症
    • その他

第9章 医薬品懸濁液市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院
    • クリニック
    • その他

第10章 医薬品懸濁液市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 医薬品懸濁液業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • Novartis AG
    • GlaxoSmithKline（GSK）
    • Sanofi
    • Roche
    • Merck &Co., Inc.
    • Bristol-Myers Squibb
    • AbbVie Inc.
    • AstraZeneca
    • Amgen Inc.
    • Glenmark Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Dr. Reddy's Laboratories
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV3655

REPORT HIGHLIGHT

Pharmaceutical Suspension Market size was valued at USD 56,345.32 Million in 2023, expanding at a CAGR of 4.3% from 2024 to 2032.

A pharmaceutical suspension is a type of liquid dosage form used in medicine. It consists of solid particles dispersed throughout a liquid medium. Unlike solutions where the active ingredient is fully dissolved, in suspensions, the active ingredient remains undissolved and is suspended in the liquid.

Pharmaceutical Suspension Market- Market Dynamics

Advancement in drug delivery technologies and increasing R&D investment is expected to propel market demand

Innovations in drug delivery systems and formulation technologies enhance the efficacy and stability of suspensions. Improved technologies for creating stable, high-quality suspensions help meet the needs of complex medications, which is boosting market growth. The increasing incidence of chronic conditions such as diabetes, cancer, and respiratory diseases drives the demand for various pharmaceutical formulations, including suspensions. These formulations are particularly useful for patients who need medication in a liquid form. Further, Advances in manufacturing processes, such as better mixing and milling techniques, improve the quality and consistency of pharmaceutical suspensions, making them more attractive to both manufacturers and consumers.

Increased investment in research and development by pharmaceutical companies to create new and improved formulations drives market growth. This includes developing suspensions for new drugs or improving existing products. Moreover, the demand for over the counter (OTC) medications in suspension form, such as antacids, cough syrups, and pain relievers, continues to grow, driven by consumer preference for convenient and accessible treatments.

Pharmaceutical Suspension Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2024-2032)

Based on Type segmentation, the parenteral segment was predicted to show maximum market share in the year 2023, owing to its rapid & direct route for drug delivery.

Based on Indication segmentation, the cancer segment was the leading Indication in 2023, owing to the large availability of cancer drugs.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, owing to the increasing prevalence of cancer, chronic disorders.

Based on region, North America was the leading revenue generator in 2023, due to the wide availability of suspension-based medications.

Pharmaceutical Suspension Market- Segmentation Analysis:

The Global Pharmaceutical Suspension Market is segmented based on Type, Indication, End User, and Region.

The market is divided into three categories based on Type: oral, parenteral, and others. The parenteral segment dominates the market. Advancements in parenteral drug formulations and their greater adoption are mainly boosting market growth.

The market is divided into five categories based on Indication: cancer, gastrointestinal, neurological, infectious disease, and others. The cancer segment dominates the market. The growing development in therapeutic areas and technology is stimulating segment growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The improved chronic disease treatment and therapy are proliferating segment growth.

Pharmaceutical Suspension Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is a major market due to its large population, rising healthcare expenditure, and increasing prevalence of chronic diseases. The region has countries like China, India, and Japan which are significant hubs for pharmaceutical manufacturing. The Middle East & Africa market is relatively underdeveloped compared to other regions, but there is growing interest due to increasing healthcare access and rising awareness of various treatment options.

Pharmaceutical Suspension Market- Competitive Landscape:

The pharmaceutical suspension market is significantly dynamic, with ongoing advancements and competitive strategies shaping its evolution. Companies that leverage technological innovation, and strategic partnerships. Leading companies focus on innovation to differentiate their products and maintain a competitive edge. This includes developing new formulations, improving drug delivery systems, and investing in research and development. Companies often collaborate with academic institutions and research organizations to advance the science of drug delivery and develop innovative suspension formulations.

In August 2023, Merck & Co., Inc., a leading global biopharmaceutical company, announced the approval of an expanded indication for ERVEBO for the disease called Zaire ebolavirus.

In November 2023, Teva Pharmaceutical Industries and Royalty Pharma plc, partnered to accelerate their clinical research program.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL SUSPENSION MARKET KEY PLAYERS

  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • GlaxoSmithKline (GSK)
  • Sanofi
  • Roche
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • AbbVie Inc.
  • AstraZeneca
  • Amgen Inc.
  • Glenmark Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Dr. Reddy's Laboratories
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Oral
  • Parenteral
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Cancer
  • Gastrointestinal
  • Neurological
  • Infectious Disease
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Suspension Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Suspension Market Snippet by Type
    • 2.1.2. Pharmaceutical Suspension Market Snippet by Indication
    • 2.1.3. Pharmaceutical Suspension Market Snippet by End User
    • 2.1.4. Pharmaceutical Suspension Market Snippet by Country
    • 2.1.5. Pharmaceutical Suspension Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Suspension Key Market Trends

  • 3.1. Pharmaceutical Suspension Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Suspension Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Suspension Market Opportunities
  • 3.4. Pharmaceutical Suspension Market Future Trends

4. Pharmaceutical Suspension Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Suspension Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pharmaceutical Suspension Market Landscape

  • 6.1. Pharmaceutical Suspension Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Suspension Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Oral
    • 7.1.3. Parenteral
    • 7.1.4. Others

8. Pharmaceutical Suspension Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Gastrointestinal
    • 8.1.4. Neurological
    • 8.1.5. Infectious Disease
    • 8.1.6. Others

9. Pharmaceutical Suspension Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Pharmaceutical Suspension Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharmaceutical Suspension Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharmaceutical Suspension Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharmaceutical Suspension Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pharmaceutical Suspension Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pharmaceutical Suspension Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Suspension Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Johnson & Johnson
    • 11.2.3. Novartis AG
    • 11.2.4. GlaxoSmithKline (GSK)
    • 11.2.5. Sanofi
    • 11.2.6. Roche
    • 11.2.7. Merck & Co., Inc.
    • 11.2.8. Bristol-Myers Squibb
    • 11.2.9. AbbVie Inc.
    • 11.2.10. AstraZeneca
    • 11.2.11. Amgen Inc.
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Teva Pharmaceutical Industries Ltd.
    • 11.2.14. Mylan N.V.
    • 11.2.15. Dr. Reddy's Laboratories
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us